These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 12007950

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.
    Sur RK, Donde B, Levin VC, Mannell A.
    Int J Radiat Oncol Biol Phys; 1998 Jan 15; 40(2):447-53. PubMed ID: 9457834
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center.
    Bhatt L, Tirmazy S, Sothi S.
    Dis Esophagus; 2013 Jan 15; 26(1):57-60. PubMed ID: 22404484
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases.
    Ghosh S, Sau S, Mitra S, Manna A, Ghosh K.
    J Indian Med Assoc; 2012 Jul 15; 110(7):449-52. PubMed ID: 23520668
    [Abstract] [Full Text] [Related]

  • 7. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy.
    Sharma V, Mahantshetty U, Dinshaw KA, Deshpande R, Sharma S.
    Int J Radiat Oncol Biol Phys; 2002 Feb 01; 52(2):310-5. PubMed ID: 11872275
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of multidisciplinary treatment with high dose rate intraluminal brachytherapy on survival in patients with unresectable esophageal cancer.
    Iwasa M, Ohmori Y, Iwasa Y, Yamamoto A, Inoue A, Maeda H, Kume M, Ogoshi S, Nishioka A, Ogawa Y, Yoshida S.
    Dig Surg; 1998 Feb 01; 15(3):227-35. PubMed ID: 9845590
    [Abstract] [Full Text] [Related]

  • 11. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group.
    Okawa T, Dokiya T, Nishio M, Hishikawa Y, Morita K.
    Int J Radiat Oncol Biol Phys; 1999 Oct 01; 45(3):623-8. PubMed ID: 10524414
    [Abstract] [Full Text] [Related]

  • 12. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study.
    Calais G, Dorval E, Louisot P, Bourlier P, Klein V, Chapet S, Reynaud-Bougnoux A, Huten N, De Calan L, Aget H, Le Floch O.
    Int J Radiat Oncol Biol Phys; 1997 Jul 01; 38(4):769-75. PubMed ID: 9240645
    [Abstract] [Full Text] [Related]

  • 13. Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors.
    Niemoeller OM, Pöllinger B, Niyazi M, Corradini S, Manapov F, Belka C, Huber RM.
    Radiat Oncol; 2013 Jan 07; 8():8. PubMed ID: 23289530
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA.
    Gaspar LE, Nag S, Herskovic A, Mantravadi R, Speiser B.
    Int J Radiat Oncol Biol Phys; 1997 Apr 01; 38(1):127-32. PubMed ID: 9212013
    [Abstract] [Full Text] [Related]

  • 16. Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors.
    Huber RM, Fischer R, Hautmann H, Pöllinger B, Häussinger K, Wendt T.
    Int J Radiat Oncol Biol Phys; 1997 Jun 01; 38(3):533-40. PubMed ID: 9231677
    [Abstract] [Full Text] [Related]

  • 17. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
    Mayer A, Nemeskéri C, Petneházi C, Borgulya G, Varga S, Naszály A.
    Strahlenther Onkol; 2004 Apr 01; 180(4):209-15. PubMed ID: 15057431
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Salvage high-dose-rate brachytherapy for esophageal cancer in previously irradiated patients: A retrospective analysis.
    Wong Hee Kam S, Rivera S, Hennequin C, Lourenço N, Chirica M, Munoz-Bongrand N, Gornet JM, Quéro L.
    Brachytherapy; 2015 Apr 01; 14(4):531-6. PubMed ID: 25906950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.